INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $19 | -48.6% | 23,408 | 0.0% | 0.00% | – |
Q4 2022 | $37 | -99.9% | 23,408 | 0.0% | 0.00% | – |
Q3 2022 | $40,000 | 0.0% | 23,408 | 0.0% | 0.00% | – |
Q2 2022 | $40,000 | -52.4% | 23,408 | 0.0% | 0.00% | – |
Q1 2022 | $84,000 | -28.2% | 23,408 | 0.0% | 0.00% | – |
Q4 2021 | $117,000 | -30.4% | 23,408 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $168,000 | -22.6% | 23,408 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $217,000 | 0.0% | 23,408 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $217,000 | +4.8% | 23,408 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $207,000 | -23.9% | 23,408 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $272,000 | -56.9% | 23,408 | 0.0% | 0.00% | -75.0% |
Q2 2020 | $631,000 | – | 23,408 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|